There have been several high profile merger and acquisition deals that took place this past week. St. Jude has decided to buy Thoratec for $3.4B, Allergan has acquired NMDA depression drugs in a $560M-plus Naurex buyout, and Teva has inked a $40B-plus pact for Allergan’s generics biz. M&A deals are the quickest way for a company to expand and grow in the market. St. Jude has announced its intention to acquire Thoratec for $3.4 billion, looking to incorporate its ventricular assist devices into St. Jude’s cardiology portfolio. St. Jude’s portfolio
Read More